We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NBY market cap is 2.59M. The company's latest EPS is USD -3.4175 and P/E is -0.16.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.27M | 3.73M | 2.63M | 2.4M | 2.44M |
| Operating Income | -1.12M | -3.39M | -2.44M | -1.05M | -1.06M |
| Net Income | -1.76M | -9.17M | -3.59M | -1.59M | -2.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.6M | 9.93M | 8.42M | 14.4M | 14.73M |
| Operating Income | -9.4M | -6.43M | -8.86M | -14.42M | -7.6M |
| Net Income | -10.46M | -11.04M | -6.56M | -16.27M | -16.7M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.85M | 9.03M | 5.36M | 3.93M | 3.88M |
| Total Liabilities | 5.82M | 5.72M | 5.2M | 4.54M | 2.81M |
| Total Equity | 7.04M | 3.31M | 160k | -617k | 1.07M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.22M | 15.24M | 23.98M | 16.4M | 9.03M |
| Total Liabilities | 10.25M | 2.92M | 13.81M | 5.85M | 5.72M |
| Total Equity | 973k | 12.32M | 10.17M | 10.55M | 3.31M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.82M | -4.13M | -1.57M | -2.15M | -4.37M |
| Investing | -17k | -19k | 1.07M | 1.07M | 1.02M |
| Financing | 1.94M | 1.91M | -597k | -1.09M | 1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.93M | -4.72M | -9.19M | -6.65M | -4.13M |
| Investing | -19k | -26k | -12.05M | -112k | -19k |
| Financing | 11.7M | 9.76M | 16.79M | 4.63M | 1.91M |
| Market Cap | 2.59M |
| Price to Earnings Ratio | -0.16 |
| Price to Sales Ratio | 0.18 |
| Price to Cash Ratio | 0.84 |
| Price to Book Ratio | 0.8 |
| Dividend Yield | - |
| Shares Outstanding | 4.89M |
| Average Volume (1 week) | 96.56k |
| Average Volume (1 Month) | 72.97k |
| 52 Week Change | -94.76% |
| 52 Week High | 10.15 |
| 52 Week Low | 0.3611 |
| Spread (Intraday) | 0.01 (1.19%) |
| Company Name | NovaBay Pharmaceuticals Inc New |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.novabay.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
